Robotic-assisted hip and knee replacement surgery does not reduce the overall early risk of repeat surgery compared with conventional procedures, according to major studies published in the BMJ. The research, which analyzed more than one million joint replacements recorded in the National Joint Registry between 2018 and 2024, found that despite the greater technical precision of robotic systems, those clinical benefits did not translate into a lower overall reoperation rate for patients in the early years following their operations.
National Joint Registry Data Reveals Early Surgical Outcomes
Researchers from Queen Mary University of London, the University of Oxford, and the University of Bristol examined 1,073,436 joint replacements performed between 2018 and 2024. The evaluation utilized target trial emulation, a statistical approach designed to balance patient characteristics and make real-world registry data closely resemble a randomized clinical trial. While robotic hip replacement showed a lower risk of further surgery specifically for implant positioning problems, that specific advantage did not lower the overall need for repeat procedures. For knee replacements, researchers observed no difference in repeat surgery risks between robotic-assisted methods and conventional techniques.
Financial Investment and NHS Robotic Surgery Expansion Plans
The cost of robotic systems is approximately £1 million to introduce, with an additional £1000 to £2,500 added to the cost of each individual operation. The National Health Service plans a major expansion of robotic surgery, aiming to increase the volume of robotic procedures sevenfold by 2035. In these procedures, the human surgeon remains entirely in control of the operation, utilizing computer and robotic technology to plan and execute implant placement.
Independent Evidence for Policymakers and Surgeons
This study, which uses novel methodology and represents the largest real-world analysis of its kind worldwide, provides important independent evidence for patients, surgeons and policymakers at a time when robotic hip and knee replacement surgery is being adopted rapidly,
said Dr. Hasan Mohammad, Academic Clinical Lecturer in Trauma and Orthopaedics at Queen Mary University of London and lead author of the study. Mohammad also emphasized that new technology must deliver meaningful patient benefits and represent good value for publicly funded health services. The research team stated that longer-term follow-up is necessary to establish whether differences in implant survival emerge over time.
Frequently Asked Questions About Joint Replacement Studies
What data sources were used for the joint replacement research?
Researchers analyzed more than one million joint replacements recorded in the National Joint Registry between 2018 and 2024 using a target trial emulation statistical method.
Which academic institutions conducted the studies published in the BMJ?
The studies were conducted by researchers from Queen Mary University of London, the University of Oxford, and the University of Bristol.
What specific financial costs are associated with robotic surgical systems?
Introducing robotic surgical systems costs around £1 million, while adding between £1,000 and £2,500 to the cost of each individual procedure.
Related reading